
Last updated: 2026-10-18 03:16:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Nyxoah SA (NYXH) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.12, with a market capitalization of $121.19M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.11 to $6.00. This page covers its latest market performance, valuation, price trends and company information.
$121.19M | |
$1.19 | |
$37.00 | |
$1.11 | |
$1.19 | |
207.68K | |
275.20K | |
-- | |
$6.00 | |
$1.11 | |
-- | |
-- |
Nyxoah SA (NYXH) last closed at $1.19 as of 2026-10-16 23:32:00, unchanged from the previous close of $1.19.
During the latest regular trading session, NYXH traded between $1.11 and $37.00, with a volume of 207.68K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Nyxoah SA (NYXH) moved from $1.35 to $1.12, representing a decline of 17.11% ($0.23).
The stock traded between $1.11 and $1.39 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 109.13 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.2%
NYXH is currently trading at $1.12, placing it 0.2% of the way from its 52-week low of $1.11 to its 52-week high of $6.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
| Employees | 154 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Nyxoah SA (NYXH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.